Our Remarkable Journey
We've consistently demonstrated our commitment to excellence by navigating through various audits conducted by regulatory authorities and customers globally, solidifying our growth and reputation in the field.
Our journey in the pharmaceutical industry has been defined by a succession of pivotal achievements.
KEY MILESTONES
1992
Manisha & Kumar Private Limited was established.
1997
Manisha & Kumar Private Limited developed its first Scopolamine/Hyoscine Salt.
2000
Manisha & Kumar first Block in the manufacturing facility, was inaugurated.
2002
Manisha & Kumar Private Limited received its first Certificate of Suitability (CEP) for Hyoscine Butylbromide.
2007
Block II, expanding Manisha & Kumar manufacturing capacity, was inaugurated.
2009
Manisha & Kumar Private Limited attained its first KMFDS accreditation.
2011
Manisha & Kumar Private Limited completed its first USFDA audit, resulting in facility acceptance.
2013
Block III, Manisha & Kumar largest manufacturing facility to date, wass inaugurated. Manisha & Kumar also acquired its first piece of farmland in Australia for biomass.
2014
Manisha & Kumar Private Limited established its Process Development Lab.
2015
Manisha & Kumar Private Limited successfully cleared its first TGA Audit
2018
Manisha & Kumar Private Limited completed its first EDQM audit.
2019
The Potent Molecule Handling Block was established in Block III.
What We Have Accomplished
Manisha & Kumar milestones underscore its commitment to quality and compliance, as well as its unwavering dedication to pushing the boundaries of pharmaceutical innovation. Each achievement is a testament to the company's enduring pursuit of excellence.
31
Years in business
85
Countries Served
Get To Know More
About our products, send us a query or
download our catalog.